内质网
纳米器件
内质网相关蛋白降解
自噬
细胞生物学
细胞器
溶酶体
细胞质
未折叠蛋白反应
蛋白质降解
化学
伴侣(临床)
膜蛋白
细胞内
膜
生物
生物化学
纳米技术
酶
材料科学
病理
细胞凋亡
医学
作者
Caixia Liu,Bin Wang,Weiping Zhu,Yufang Xu,Yangyang Yang,Xuhong Qian
标识
DOI:10.1002/anie.202205509
摘要
Abstract Targeted protein degradation via proteasomal and lysosomal pathways is a promising therapeutic approach, and proteins in cytoplasm or on the cell membrane can be easily contacted and have become the major targets. However, degradation of disease‐related proteins that exist in membrane‐bound organelles (MBO) such as the endoplasmic reticulum (ER) remains unsolved due to the membrane limits. Here we describe a DNA nanodevice that shows ER targeting capacity and undergoes new intracellular degradation via the autophagy‐dependent pathway. Then the DNA nanostructure functionalized with specific ligands is used to selectively catch ER‐localized proteins and then transport them to the lysosome for degradation. Through this technique, the degradation of both exogenous ER‐resident protein (ER‐eGFP) and endogenous overexpressed molecular chaperone (glucose‐regulated protein 78) in cancer cells has been successfully executed with high efficiency.
科研通智能强力驱动
Strongly Powered by AbleSci AI